Commercial Launch of Xact Device Undewsay

My Subscriptions

Payment Confirmation

Transaction Failed

Your transaction failed, please try again or contact site support.

Cypris Medical, Inc. announced today the commercial release of its Xact device for minimally invasive face and neck lift suturing.

“I’m excited that Cypris Medical is the first to effectively address a sizable unmet need in facial aesthetics,” said Dan Holton, Chief Executive Officer. “The first application of our Xact technology is designed to provide surgical outcomes of gravitational descent in the face and neck via a minimally invasive procedure. The device has already developed a strong patient satisfaction track record. It’s a favorable solution for the millions of patients who need more than neurotoxins and fillers, but don’t want to undergo a full face or neck lift.” He added, “The technology is the first of its kind in plastic surgery and is being extended to additional applications currently under development. We are incredibly proud to spearhead a new generation of minimally invasive plastic surgery.”

The Xact suturing device achieved FDA clearance in April 2017. The commercial launch follows a successful evaluation period in which patients demonstrated satisfying, lasting results over two years. Procedures that use Xact are well suited to be performed without general anesthesia in out-patient settings. Procedures can be completed in less than an hour. Patients typically recover in five days or less. Comparatively, traditional facelift, browlift and necklift surgical treatments require general anesthesia and longer recovery time.

“Minimally invasive options are becoming the standard in surgical procedures throughout medicine. It’s time for plastic surgery to advance, and the Xact device is well equipped to pioneer that shift,” said Dr. Louis Bucky, a board-certified plastic surgeon, who serves on the Cypris Medical Advisory Board.

“Xact technology will absolutely transform our industry’s treatment of facial aging,” said Dr. Christopher Godek, a board-certified plastic surgeon and lead clinical investigator for Xact. “This innovation can replace previous technologies, such as thread lifts, which have proven ineffective due to imprecise anatomic targets, limited longevity and high complication rates including thread extrusion. The Xact device effectively extends a surgeon’s hands into hard-to-reach areas. Utilizing small, two-centimeter-long incisions hidden within the hairline, surgeons can accurately and precisely lift, reposition and suture tissue.”

Xact is a hand-held surgical suturing device designed to approximate and passsuture through soft tissue. Xact extends a surgeon’s hands allowing them to place sutures precisely with less tissue disruption. This makes procedures that use Xact less invasive which speeds recovery time. Xact can be used in any procedure that requires precise delivery of a suture.



Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.